Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimer’s Disease
Author
Abstract
Suggested Citation
DOI: 10.2165/11531870-000000000-00000
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Nick Bosanquet & Andrew Yeates, 2006. "Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer’s Disease," PharmacoEconomics, Springer, vol. 24(6), pages 623-625, June.
- Denis Getsios & Kristen Migliaccio-Walle & Jaime Caro, 2007. "NICE Cost-Effectiveness Appraisal of Cholinesterase Inhibitors," PharmacoEconomics, Springer, vol. 25(12), pages 997-1006, December.
- Brazier, John & Roberts, Jennifer & Deverill, Mark, 2002. "The estimation of a preference-based measure of health from the SF-36," Journal of Health Economics, Elsevier, vol. 21(2), pages 271-292, March.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- L. M. Peña-Longobardo & B. Rodríguez-Sánchez & J. Oliva-Moreno & I. Aranda-Reneo & J. López-Bastida, 2019. "How relevant are social costs in economic evaluations? The case of Alzheimer’s disease," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1207-1236, November.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Majmudar, Ishani Kartik & Mihalopoulos, Cathy & Abimanyi-Ochom, Julie & Mohebbi, Mohammadreza & Engel, Lidia, 2024. "The association between loneliness with health service use and quality of life among informal carers in Australia," Social Science & Medicine, Elsevier, vol. 348(C).
- Samer A. Kharroubi & Yara Beyh & Marwa Diab El Harake & Dalia Dawoud & Donna Rowen & John Brazier, 2020. "Examining the Feasibility and Acceptability of Valuing the Arabic Version of SF-6D in a Lebanese Population," IJERPH, MDPI, vol. 17(3), pages 1-15, February.
- Nick Bansback & Huiying Sun & Daphne P. Guh & Xin Li & Bohdan Nosyk & Susan Griffin & Paul G. Barnett & Aslam H. Anis, 2008. "Impact of the recall period on measuring health utilities for acute events," Health Economics, John Wiley & Sons, Ltd., vol. 17(12), pages 1413-1419.
- Natalia Hernández-Segura & Alba Marcos-Delgado & Arrate Pinto-Carral & Tania Fernández-Villa & Antonio J. Molina, 2022. "Health-Related Quality of Life (HRQOL) Instruments and Mobility: A Systematic Review," IJERPH, MDPI, vol. 19(24), pages 1-23, December.
- Clarke, Philip & Erreygers, Guido, 2020.
"Defining and measuring health poverty,"
Social Science & Medicine, Elsevier, vol. 244(C).
- CLARKE, Philip & ERREYGERS, Guido, 2018. "Defining and measuring health poverty," Working Papers 2018011, University of Antwerp, Faculty of Business and Economics.
- Richard Grieve & Marina Grishchenko & John Cairns, 2009. "SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(1), pages 15-23, February.
- Miguel A. Garcia-Gordillo & Daniel Collado-Mateo & Pedro R. Olivares & José C. Adsuar, 2018. "Chilean population norms derived from the health-related quality of Life SF-6D," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(5), pages 675-686, June.
- Nadja Chernyak & Heribert Sattel & Marsel Scheer & Christina Baechle & Johannes Kruse & Peter Henningsen & Andrea Icks, 2014. "Economic Evaluation of Brief Psychodynamic Interpersonal Therapy in Patients with Multisomatoform Disorder," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-4, January.
- Francesca Cornaglia & Naomi E. Feldman & Andrew Leigh, 2014.
"Crime and Mental Well-Being,"
Journal of Human Resources, University of Wisconsin Press, vol. 49(1), pages 110-140.
- Cornaglia, Francesca & Leigh, Andrew, 2011. "Crime and mental wellbeing," LSE Research Online Documents on Economics 121729, London School of Economics and Political Science, LSE Library.
- Cornaglia, Francesca & Feldman, Naomi E. & Leigh, Andrew, 2014. "Crime and Mental Wellbeing," IZA Discussion Papers 8014, Institute of Labor Economics (IZA).
- Francesca Cornaglia & Andrew Leigh, 2012. "Crime and mental wellbeing," CentrePiece - The magazine for economic performance 357, Centre for Economic Performance, LSE.
- Francesca Cornaglia & Andrew Leigh, 2011. "Crime and Mental Wellbeing," CEP Discussion Papers dp1049, Centre for Economic Performance, LSE.
- John A. Nyman, 2012. "Productivity Costs Revisited: Toward A New Us Policy," Health Economics, John Wiley & Sons, Ltd., vol. 21(12), pages 1387-1401, December.
- Xinyu Qian & Rachel Lee-Yin Tan & Ling-Hsiang Chuang & Nan Luo, 2020. "Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic Review," PharmacoEconomics, Springer, vol. 38(2), pages 159-170, February.
- Ratcliffe, Julie & Huynh, Elisabeth & Chen, Gang & Stevens, Katherine & Swait, Joffre & Brazier, John & Sawyer, Michael & Roberts, Rachel & Flynn, Terry, 2016. "Valuing the Child Health Utility 9D: Using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm," Social Science & Medicine, Elsevier, vol. 157(C), pages 48-59.
- Stavros Petrou & Oliver Rivero-Arias & Helen Dakin & Louise Longworth & Mark Oppe & Robert Froud & Alastair Gray, 2015.
"Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement,"
Medical Decision Making, , vol. 35(6), pages 1-8, August.
- Stavros Petrou & Oliver Rivero-Arias & Helen Dakin & Louise Longworth & Mark Oppe & Robert Froud & Alastair Gray, 2015. "Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement," Applied Health Economics and Health Policy, Springer, vol. 13(5), pages 437-443, October.
- Stavros Petrou & Oliver Rivero-Arias & Helen Dakin & Louise Longworth & Mark Oppe & Robert Froud & Alastair Gray, 2015. "Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement," PharmacoEconomics, Springer, vol. 33(10), pages 985-991, October.
- Musal, R. Muzaffer & Soyer, Refik & McCabe, Christopher & Kharroubi, Samer A., 2012. "Estimating the population utility function: A parametric Bayesian approach," European Journal of Operational Research, Elsevier, vol. 218(2), pages 538-547.
- Garry R. Barton & Tracey H. Sach & Anthony J. Avery & Claire Jenkinson & Michael Doherty & David K. Whynes & Kenneth R. Muir, 2008. "A comparison of the performance of the EQ‐5D and SF‐6D for individuals aged ≥ 45 years," Health Economics, John Wiley & Sons, Ltd., vol. 17(7), pages 815-832, July.
- Anirban Basu & William Dale & Arthur Elstein & David Meltzer, 2009. "A linear index for predicting joint health‐states utilities from single health‐states utilities," Health Economics, John Wiley & Sons, Ltd., vol. 18(4), pages 403-419, April.
- McCabe, Christopher & Brazier, John & Gilks, Peter & Tsuchiya, Aki & Roberts, Jennifer & O'Hagan, Anthony & Stevens, Katherine, 2006. "Using rank data to estimate health state utility models," Journal of Health Economics, Elsevier, vol. 25(3), pages 418-431, May.
- John Brazier & Donna Rowen & Yaling Yang & Aki Tsuchiya, 2012. "Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(5), pages 575-587, October.
- Thomas Reinhold & Claudia Witt & Susanne Jena & Benno Brinkhaus & Stefan Willich, 2008. "Quality of life and cost-effectiveness of acupuncture treatment in patients with osteoarthritis pain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 9(3), pages 209-219, August.
- Kontodimopoulos, Nick & Niakas, Dimitris, 2008. "An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy," Health Policy, Elsevier, vol. 86(1), pages 85-96, April.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:28:y:2010:i:5:p:411-427. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.